KNOWLEDGE BANK

Interviews

Rise of Enabling Technologies in Pharmaceutical Formulation Development and Manufacturing

Director, Formulation Development, Exelixis, Inc
Kasturi Pawar is a leading pharmaceutical scientist with a PhD in pharmaceutical sciences She has significantly contributed to the field of pharmaceutics Her research and experience have been focused on formulation development drug delivery and clinical supply chain Currently working as a Director in Formulation Development at Exelixis Inc she holds several publications and patents on drug deliver...

Articles

The Exosome Manufacturing Gap

Extracellular vesicles EVs including exosomes have been touted as the next big thing in the biopharmaceuticals arena for the last decade Exosomes are naturally occurring vesicles of nanosized nm which are secreted by almost all eukaryotic cells The exosomes have been differentiated from other vesicles including apoptotic bodies at the molecular level from their biogenesis pathway

Research Insights

Host Centric Drug Repurposing for Viral Diseases

Computational approaches for drug repurposing for viral diseases have mainly focused on a small number of antivirals that directly target pathogens virus centric therapies In this work we combine ideas from collaborative

Case Studies

An Observational Case Study Of Prescription Patterns Of Antibiotics In Treating Lower Respiratory Tract Infections

Abstract Antibiotics are of the oldest discovered drugs that combat specific micro organisms like bacteria and fungi Although there are several classification schemes for antibiotics based on bacterial spectrum broad vs narrow or route of administration injectable vs oral vs topical or type of activity bactericidal vs bacteriostatic the most usefu

Techno Trends

Ultragenyx Pharmaceutical Developed First-of-its-kind Setrusumab (UX143) for Osteogenesis Imperfecta

Ultragenyx Pharmaceutical has developed setrusumab UX a groundbreaking treatment aimed at reducing the fracture risk associated with osteogenesis imperfecta OI Types I III or IV in patients aged years and older

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

A Structured Review on BCRP-Mediated Multidrug Resistance

Nensi Raytthatha

Nensi Raytthatha Research Scholar, Sigma Institute of Pharmacy, Vadodara. She has published more than 5 research and review papers in reputed journals. She has presented more than 10 posters and have attended national and international conferences.

 

Isha Shah

Isha Shah, Research Scholar, Sigma Institute of Pharmacy, Vadodara. She has published five research and review papers in reputed journals. She has presented more than 10 posters and have attended national and international conferences.

 

Jigar Vyas

Jigar Vyas has more than 16 years of teaching and research experience. He has guided more than 40 PG students and has published more than 50 research and review papers. He has received of IQAC award for quality, performance in teaching and research.

 

2

Homeopathic Science

Aditya Dilipkumar Patil

Aditya Dilipkumar Patil pursed B.H.M.S. and MD (Hom) from Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College and Post Graduate Research Centre, Pune. He is currently working as Assistant Professor in Department of Homoeopathic Pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018. He is a member of Chandrabhaga Charitable trust since 2017 and Life member of Moredada Charitable Trust, Nashik, Department of Herbal Medicine since 2018. He was working as Senior Research Fellow in Central Council for Research in Homoepathy (CCRH under Ministry of AYUSH). His main research work focuses on Evidenced based medicine, Diabetes, preclinical studies (In-vitro & In-vivo), nanoparticle etc.

 

Parth Sanjeev Aphale

Parth Sanjeev Aphale pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from Foster Development Homoeopathic Medical College, Aurangabad. He is currently working as Professor in Department of Homoeopathic pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.

 

Dharmendra Basudeo Sharma

Dharmendra Basudeo Sharma pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from University of Rajasthan and Ph.D from Maharashtra University of Health Science (MUHS). He is currently working as Principal and Head of Institute at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.

 

3

Transforming Customer Engagement in Life Sciences Adopting Hybrid Commercial Models (HCMs)

Rohit K

 

 is a Practice Director at the Life Sciences IT Services team, leading commercial technology research and client engagements. He has worked with business and IT leaders on strategy, M&A, and market intelligence. Previously a Consultant at EY, Rohit holds an MBA from FMS, Delhi University, and an engineering degree from NIT Jalandhar.

4

The Unknown Sources of Error in the Pharmaceutical Weighing Process

Thomas Caratsch

Thomas Caratsch has been the Head of Laboratory Division since December 2007 at the company's headquarters in Greifensee, Switzerland. Prior to joining the company, Caratsch held various management positions within the Hoffmann La Roche group in the U.S. and Switzerland, including General Manager of Roche Instrument Centre AG and Head of Disetronic Medical Systems AG. He began his career as a development engineer at Sodeco-Saia in Geneva.

5

Decoding Antisense Oligonucleotides: Mechanisms, Applications, and Future Directions

Dr. Arun Shastry

Dr. Arun Shastry is a Bengaluru-based scientist with a PhD in Immunogenetics. He is the Co-Founder, Managing Director, and Chief Scientific Officer (CSO) of Hanugen Therapeutics, a pioneering biopharmaceutical company focused on oligonucleotide-based therapies for rare genetic diseases, particularly Duchenne Muscular Dystrophy (DMD). With over two decades in drug discovery for rare disorders, Dr. Shastry drives affordable, accessible treatments through innovative personalized medicine approaches in India.

press releasesRead more...

Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery

AIdriven protein design is accelerating the discovery of novel protein binders but experimental validation remains essential to determine whether computational designs translate into meaningful target interactions To bridge this gap Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in r...

Innovent Announces Positive CHMP Opinion, Recommending Zybrivo® (sintilimab) for First-Line Treatment of Non-squamous Non-Small Cell Lung Cancer

Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncologic autoimmune cardiovascular and metabolic

Biocon Limited BSE NSE BIOCON an innovationled global biopharmaceutical company today announced that the US Food and Drug Administration FDA has approved Pebrilzo pertuzumabqcay a biosimilar of the reference

LOTTE Biologics Secures Major Commercial Manufacturing Agreement Ahead of Songdo Plant 1 Launch

LOTTE Biologics CoCEOs James Park and Yooyeol Shin today announced a major commercial manufacturing agreement with a global pharmaceutical company marking a significant milestone in the commercialization of its Songdo Bio Campus

Akeso Announces NMPA Acceptance of sNDA for Ivonescimab in Combination with Chemotherapy for First-Line Biliary Tract Cancer

Akeso Inc HK Akeso or the Company announced that the National Medical Products Administration NMPA of China has accepted the supplemental New Drug Application sNDA for ivonescimab in combination with chemotherapy

Biomapas Establishes Us Presence With Acquisition of Alira Health’s Cmc Business

Biomapas a leading integrated life sciences services provider today announced its entry into the US market with the acquisition of the Chemistry Manufacturing and Controls CMC business of Alira Health The Bostonbased team which provides integrated

EventsRead more...

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

01 - 03

Dec 2026

Pharmaceutical Launch Excellence Summit

Novotel Amsterdam City, Nether...

01 - 03

Dec 2026

10th Antifibrotic Drug Development

Boston, MA at the Hotel Common...

02 - 04

Dec 2026

Genome Informatics 2026

Wellcome Genome Campus, UK

03 - 04

Dec 2026

LATEST NEWSRead more...

OBI Pharma and Novartis Partner to Develop Next-Generation ADCs for Cancer Treatment

OBI Pharma has entered into a collaboration and licensing agreement with Novartis to develop nextgeneration antibodydrug conjugates ADCs using novel payloads and OBIs proprietary technology platforms

Merck to Acquire Rapid Micro Biosystems to Strengthen Automation in Pharmaceutical Quality Control

Merck has signed a definitive agreement to acquire Rapid Micro Biosystems a USbased provider of automated microbial qualitycontrol testing solutions for pharmaceutical manufacturing

Immuneering Enters into Collaboration with Astellas to Evaluate Combination Therapies for Pancreatic Cancer

Immuneering has entered into a clinical trial collaboration and supply agreement with Astellas Pharma to evaluate investigational combination therapies for patients with pancreatic cancer

Eppendorf Invests €40 Million in New Manufacturing Facility in Penang, Malaysia

Eppendorf has started construction of a new manufacturing facility at Bandar Cassia Technology Park in Penang Malaysia

Lilly Invests US$3.5 Billion in New Manufacturing Facility for Obesity Medicines in Pennsylvania

Eli Lilly and Company has started construction of a US billion manufacturing facility in Lehigh Valley Pennsylvania as part of its plans to expand medicine production in the United States The new site is one of manufacturing facilities

Natera Enters into Collaboration with Incyte for Phase II Trial in Colorectal Cancer

Natera a precision medicine company has entered into a clinical collaboration with Incyte to support a new Phase II study evaluating an investigational treatment for colorectal cancer CRC